Human immunodeficiency virus–related lymphoma: relation between clinical features and histologic subtypes-Reference-Cited by-同舟云学术

Human immunodeficiency virus–related lymphoma: relation between clinical features and histologic subtypes

Published:2001-12 Issue:9 Volume:111 Page:704-711
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Gabarre Jean,Raphael Martine,Lepage Eric,Martin Antoine,Oksenhendler Eric,Xerri Luc,Tulliez Micheline,Audouin Josée,Costello Régis,Golfier Jean Baptiste,Schlaifer Daniel,Hequet Olivier,Azar Nabih,Katlama Christine,Gisselbrecht Christian

Publisher

Elsevier BV

Subject

General Medicine

Reference49 articles.

1. Disease progression and survival following specific AIDS-defining conditions;Petruckevitch;AIDS,1998

3. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons;Jones;J Acquir Immune Defic Syndr,1999

4. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults;J Natl Cancer Inst,2000

5. Changes in acquired immunodeficiency syndrome–related lymphoma since the introduction of highly active antiretroviral therapy;Matthews;Blood,2000

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features;Blood;2024-07-11

2. Lymph Node Penetration From Gastric Burkitt Lymphoma in a Patient Living With HIV/AIDS;Cureus;2024-02-09

3. Haematological Diseases in the Tropics;Manson's Tropical Diseases;2024

4. A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted EPOCH (+/−R) Regimen;Indian Journal of Hematology and Blood Transfusion;2023-04-21

5. Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study);Frontiers in Immunology;2023-03-29